Related Party Transactions (Details Narrative) |
6 Months Ended | 12 Months Ended | 15 Months Ended | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 13, 2020
AUD ($)
|
May 14, 2019
USD ($)
$ / shares
shares
|
May 14, 2019
AUD ($)
shares
|
Mar. 16, 2018
USD ($)
|
Mar. 16, 2018
AUD ($)
|
Feb. 01, 2018
USD ($)
|
Feb. 01, 2018
AUD ($)
|
May 05, 2016
USD ($)
|
May 05, 2016
USD ($)
|
May 05, 2016
AUD ($)
|
Feb. 25, 2016
USD ($)
|
Feb. 25, 2016
AUD ($)
|
Feb. 25, 2015
AUD ($)
|
Dec. 31, 2020
USD ($)
$ / shares
shares
|
Dec. 31, 2020
AUD ($)
shares
|
Jun. 30, 2020
USD ($)
|
Jun. 30, 2020
AUD ($)
|
Jun. 30, 2019
USD ($)
|
Jun. 30, 2019
AUD ($)
|
Sep. 30, 2020
shares
|
Dec. 31, 2020
AUD ($)
|
May 05, 2016
AUD ($)
|
|
Loans from related party | $ 57,024 | $ 50,993 | ||||||||||||||||||||
Due to related parties | $ 34,263 | 30,639 | ||||||||||||||||||||
Exercise price | $ / shares | ||||||||||||||||||||||
Accrued salaries | $ 83,225 | |||||||||||||||||||||
Chief Executive Officer [Member] | ||||||||||||||||||||||
Payments form related party | 68,713 | 136,606 | $ 64,377 | |||||||||||||||||||
Bonus payable amount | 137,120 | |||||||||||||||||||||
Remaining bonus amount | $ 178,256 | |||||||||||||||||||||
Bonus payable | 240,720 | 280,726 | ||||||||||||||||||||
Nathanielsz Employment Agreement [Member] | ||||||||||||||||||||||
Expired date | Feb. 25, 2019 | |||||||||||||||||||||
Annual salary | $ 205,680 | |||||||||||||||||||||
Percentage of pension of monthly salary | 9.50% | 9.50% | ||||||||||||||||||||
Percentage of bonus of annual base salary | 200.00% | 200.00% | ||||||||||||||||||||
Nathanielsz Employment Agreement [Member] | Minimum [Member] | ||||||||||||||||||||||
Annual salary | $ 205,680 | |||||||||||||||||||||
Nathanielsz Employment Agreement [Member] | Maximum [Member] | ||||||||||||||||||||||
Annual salary | $ 274,240 | |||||||||||||||||||||
Employment Agreement [Member] | ||||||||||||||||||||||
Restricted stock unit issuable | shares | 39 | 39 | ||||||||||||||||||||
Services Agreement [Member] | ||||||||||||||||||||||
Restricted stock unit issuable | shares | 20 | 20 | 20 | |||||||||||||||||||
AUD Currency [Member] | ||||||||||||||||||||||
Accrued salaries | $ 108,000 | |||||||||||||||||||||
AUD Currency [Member] | Chief Executive Officer [Member] | ||||||||||||||||||||||
Payments form related party | $ 95,000 | $ 202,620 | $ 90,000 | |||||||||||||||||||
Bonus payable amount | 200,000 | |||||||||||||||||||||
Remaining bonus amount | $ 260,000 | |||||||||||||||||||||
Bonus payable | 312,380 | $ 407,380 | ||||||||||||||||||||
AUD Currency [Member] | Nathanielsz Employment Agreement [Member] | ||||||||||||||||||||||
Annual salary | $ 25,000 | 300,000 | ||||||||||||||||||||
AUD Currency [Member] | Nathanielsz Employment Agreement [Member] | Minimum [Member] | ||||||||||||||||||||||
Annual salary | $ 300,000 | |||||||||||||||||||||
AUD Currency [Member] | Nathanielsz Employment Agreement [Member] | Maximum [Member] | ||||||||||||||||||||||
Annual salary | $ 400,000 | |||||||||||||||||||||
Initial Nathanielsz RSUs [Member] | Employment Agreement [Member] | ||||||||||||||||||||||
Restricted stock shares of common stock | shares | 39 | 39 | ||||||||||||||||||||
Additional Nathanielsz RSUs [Member] | Employment Agreement [Member] | ||||||||||||||||||||||
Restricted stock shares of common stock | shares | 39 | 39 | ||||||||||||||||||||
Rsus vest, shares | shares | 7.80 | 7.80 | ||||||||||||||||||||
Gross proceeds from equity financing | $ 4,000,000 | |||||||||||||||||||||
Initial Kenyon RSUs [Member] | Services Agreement [Member] | ||||||||||||||||||||||
Restricted stock shares of common stock | shares | 20 | 20 | ||||||||||||||||||||
Additional Kenyon RSUs [Member] | Services Agreement [Member] | ||||||||||||||||||||||
Restricted stock shares of common stock | shares | 20 | 20 | ||||||||||||||||||||
Rsus vest, shares | shares | 5 | 5 | ||||||||||||||||||||
Gross proceeds from equity financing | $ 4,000,000 | |||||||||||||||||||||
North Horizon Pty Ltd [Member] | ||||||||||||||||||||||
Lease term | 5 years | 5 years | 5 years | |||||||||||||||||||
Lease expiration date | May 31, 2021 | |||||||||||||||||||||
Annual rental payments | $ 28,325 | |||||||||||||||||||||
Goods and service tax | 2,575 | |||||||||||||||||||||
Future minimum payments due | $ 14,744 | |||||||||||||||||||||
Rent payable | 58,275 | |||||||||||||||||||||
North Horizon Pty Ltd [Member] | AUD Currency [Member] | ||||||||||||||||||||||
Annual rental payments | $ 39,600 | |||||||||||||||||||||
Goods and service tax | $ 3,600 | |||||||||||||||||||||
North Horizon Pty Ltd [Member] | AUD Currency [Member] | ||||||||||||||||||||||
Future minimum payments due | $ 19,133 | |||||||||||||||||||||
Rent payable | 75,623 | |||||||||||||||||||||
Current and Former Director [Member] | ||||||||||||||||||||||
Loans from related party | 57,024 | 50,993 | ||||||||||||||||||||
Former Director [Member] | ||||||||||||||||||||||
Due to related parties | 34,263 | $ 30,639 | ||||||||||||||||||||
Nathanielsz [Member] | North Horizon Pty Ltd [Member] | ||||||||||||||||||||||
Future minimum payments due | $ 141,629 | $ 141,629 | ||||||||||||||||||||
Nathanielsz [Member] | North Horizon Pty Ltd [Member] | AUD Currency [Member] | ||||||||||||||||||||||
Future minimum payments due | $ 198,000 | |||||||||||||||||||||
Mr. Nathanielsz [Member] | ||||||||||||||||||||||
Annual salary | $ 80,904 | |||||||||||||||||||||
Payments form related party | $ 16,684 | |||||||||||||||||||||
Mr. Nathanielsz [Member] | AUD Currency [Member] | ||||||||||||||||||||||
Annual salary | $ 120,000 | |||||||||||||||||||||
Mr. Nathanielsz [Member] | AUD Currency [Member] | ||||||||||||||||||||||
Payments form related party | $ 23,067 | |||||||||||||||||||||
James Nathanielsz [Member] | ||||||||||||||||||||||
Payments form related party | $ 3,205 | |||||||||||||||||||||
James Nathanielsz [Member] | AUD Currency [Member] | ||||||||||||||||||||||
Payments form related party | $ 4,481 | |||||||||||||||||||||
Mr. Nathanielsz [Member] | Board of Directors [Member] | ||||||||||||||||||||||
Officers' compensation | $ 315,376 | |||||||||||||||||||||
Mr. Nathanielsz [Member] | Employment Agreement [Member] | ||||||||||||||||||||||
Agreement term | 3 years | 3 years | ||||||||||||||||||||
Agreement renewal term | 1 year | 1 year | ||||||||||||||||||||
Option purchase shares | shares | 39 | 39 | ||||||||||||||||||||
Exercise price | $ / shares | $ 4,675 | |||||||||||||||||||||
Market price | 110.00% | 110.00% | ||||||||||||||||||||
Granted exercise price | $ / shares | $ 4,250 | |||||||||||||||||||||
Option term | 10 years | 10 years | ||||||||||||||||||||
Options vested, description | The Nathanielsz Options have a term of 10 years from the date of grant. 1/3rd of the Nathanielsz Options shall vest every successive one-year anniversary following the Effective Date, provided, that on each such vesting date Mr. Nathanielsz is employed by the Company and subject to the other provisions of the Employment Agreement. The Initial Nathanielsz RSUs shall vest on the one-year anniversary of the Effective Date, subject to Mr. Nathanielsz's continued employment with the Company through such vesting date. The Additional Nathanielsz RSUs will vest as follows, subject to Mr. Nathanielsz's continued employment with the Company through the applicable vesting date: (i) 7.80 of the Additional Nathanielsz RSUs shall vest upon the Company submitting Clinical Trial Application (the "CTA") for PRP, the Company's lead product candidate ("PRP"), for a First-In-Human study for PRP (the "Study") in an applicable jurisdiction to be selected by the Company, (ii) 7.80 of the Additional Nathanielsz RSUs shall vest upon the CTA being approved in an applicable jurisdiction, (iii) 7.80 of the Additional RSUs shall vest upon the Company completing an equity financing in the amount of at least $4,000,000 in gross proceeds, (iv) 7.80 of the Additional Nathanielsz RSUs shall vest upon the shares of the Company's Common Stock being listed on a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (v) the remaining 7.80 of the Additional Nathanielsz RSUs shall vest upon the Company enrolling its first patient in the Study. Each vested restricted stock unit shall be settled by delivery to Mr. Nathanielsz of one share of the Company's common stock and/or the fair market value of one share of common stock in cash, at the sole discretion of the Company's board of directors and subject to the 2019 Plan, on the first to occur of: (i) the date of a Change of Control (as defined in the Employment Agreement), (ii) the date that is ten business days following the vesting of such restricted stock unit, (iii) the date of Mr. Nathanielsz's death or Disability (as defined in the Employment Agreement), and (iv) Mr. Nathanielsz's employment being terminated either by the Company without Cause or by Mr. Nathanielsz for Good Reason (each as defined in the Employment Agreement). In the event of a Change of Control, any unvested portion of the Nathanielsz Options and such restricted stock units shall vest immediately prior to such event. | The Nathanielsz Options have a term of 10 years from the date of grant. 1/3rd of the Nathanielsz Options shall vest every successive one-year anniversary following the Effective Date, provided, that on each such vesting date Mr. Nathanielsz is employed by the Company and subject to the other provisions of the Employment Agreement. The Initial Nathanielsz RSUs shall vest on the one-year anniversary of the Effective Date, subject to Mr. Nathanielsz's continued employment with the Company through such vesting date. The Additional Nathanielsz RSUs will vest as follows, subject to Mr. Nathanielsz's continued employment with the Company through the applicable vesting date: (i) 7.80 of the Additional Nathanielsz RSUs shall vest upon the Company submitting Clinical Trial Application (the "CTA") for PRP, the Company's lead product candidate ("PRP"), for a First-In-Human study for PRP (the "Study") in an applicable jurisdiction to be selected by the Company, (ii) 7.80 of the Additional Nathanielsz RSUs shall vest upon the CTA being approved in an applicable jurisdiction, (iii) 7.80 of the Additional RSUs shall vest upon the Company completing an equity financing in the amount of at least $4,000,000 in gross proceeds, (iv) 7.80 of the Additional Nathanielsz RSUs shall vest upon the shares of the Company's Common Stock being listed on a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (v) the remaining 7.80 of the Additional Nathanielsz RSUs shall vest upon the Company enrolling its first patient in the Study. Each vested restricted stock unit shall be settled by delivery to Mr. Nathanielsz of one share of the Company's common stock and/or the fair market value of one share of common stock in cash, at the sole discretion of the Company's board of directors and subject to the 2019 Plan, on the first to occur of: (i) the date of a Change of Control (as defined in the Employment Agreement), (ii) the date that is ten business days following the vesting of such restricted stock unit, (iii) the date of Mr. Nathanielsz's death or Disability (as defined in the Employment Agreement), and (iv) Mr. Nathanielsz's employment being terminated either by the Company without Cause or by Mr. Nathanielsz for Good Reason (each as defined in the Employment Agreement). In the event of a Change of Control, any unvested portion of the Nathanielsz Options and such restricted stock units shall vest immediately prior to such event. | ||||||||||||||||||||
Mr. Nathanielsz [Member] | AUD Currency [Member] | Board of Directors [Member] | ||||||||||||||||||||||
Officers' compensation | $ 240,000 | $ 460,000 | ||||||||||||||||||||
Bonus granted percentage | 60.00% | |||||||||||||||||||||
Mr. Nathanielsz [Member] | AUD Currency [Member] | Employment Agreement [Member] | ||||||||||||||||||||||
Annual salary | $ 400,000 | |||||||||||||||||||||
Dr Kenyon [Member] | Services Agreement [Member] | ||||||||||||||||||||||
Agreement term | 3 years | 3 years | ||||||||||||||||||||
Agreement renewal term | 1 year | 1 year | ||||||||||||||||||||
Option purchase shares | shares | 20 | 20 | ||||||||||||||||||||
Exercise price | $ / shares | $ 4,250 | |||||||||||||||||||||
Market price | 100.00% | 100.00% | ||||||||||||||||||||
Option term | 10 years | 10 years | ||||||||||||||||||||
Options vested, description | The Kenyon Options have a term of 10 years from the date of grant. 1/3rd of the Kenyon Options shall vest every successive one-year anniversary following the Effective Date, provided, that on each such vesting date Dr. Kenyon is employed by the Company and subject to the other provisions of the Services Agreement. The Initial Kenyon RSUs shall vest on the one-year anniversary of the Effective Date, subject to Dr. Kenyon's continued employment with the Company through such vesting date. The Additional Kenyon RSUs will vest as follows, subject to Dr. Kenyon's continued employment with the Company through the applicable vesting date: (i) 5 of the Additional Kenyon RSUs shall vest upon the Company submitting the CTA for PRP for the Study in an applicable jurisdiction to be selected by the Company, (ii) 5 of the Additional Kenyon RSUs shall vest upon the Company completing an equity financing in the amount of at least $4,000,000 in gross proceeds, (iii) 5 of the Additional Kenyon RSUs shall vest upon the shares of the Company's Common Stock being listed on a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (iv) the remaining 5 of the Additional Kenyon RSUs shall vest upon the Company enrolling its first patient in the Study. Each vested Kenyon RSU shall be settled by delivery to Mr. Kenyon of one share of the Company's common stock and/or the fair market value of one share of common stock in cash, at the sole discretion of the Company's board of directors and subject to the Plan, on the first to occur of: (i) the date of a Change of Control (as defined in the Services Agreement), (ii) the date that is ten business days following the vesting of such Kenyon RSU, (iii) the date of Dr. Kenyon's death or Disability (as defined in the Services Agreement), and (iv) Dr. Kenyon's employment being terminated either by the Company without Cause or by Dr. Kenyon for Good Reason (as defined in the Services Agreement). In the event of a Change of Control (as defined in the Services Agreement), 50% of any unvested portion of the Kenyon Options and the Kenyon RSUs shall vest immediately prior to such event. | The Kenyon Options have a term of 10 years from the date of grant. 1/3rd of the Kenyon Options shall vest every successive one-year anniversary following the Effective Date, provided, that on each such vesting date Dr. Kenyon is employed by the Company and subject to the other provisions of the Services Agreement. The Initial Kenyon RSUs shall vest on the one-year anniversary of the Effective Date, subject to Dr. Kenyon's continued employment with the Company through such vesting date. The Additional Kenyon RSUs will vest as follows, subject to Dr. Kenyon's continued employment with the Company through the applicable vesting date: (i) 5 of the Additional Kenyon RSUs shall vest upon the Company submitting the CTA for PRP for the Study in an applicable jurisdiction to be selected by the Company, (ii) 5 of the Additional Kenyon RSUs shall vest upon the Company completing an equity financing in the amount of at least $4,000,000 in gross proceeds, (iii) 5 of the Additional Kenyon RSUs shall vest upon the shares of the Company's Common Stock being listed on a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (iv) the remaining 5 of the Additional Kenyon RSUs shall vest upon the Company enrolling its first patient in the Study. Each vested Kenyon RSU shall be settled by delivery to Mr. Kenyon of one share of the Company's common stock and/or the fair market value of one share of common stock in cash, at the sole discretion of the Company's board of directors and subject to the Plan, on the first to occur of: (i) the date of a Change of Control (as defined in the Services Agreement), (ii) the date that is ten business days following the vesting of such Kenyon RSU, (iii) the date of Dr. Kenyon's death or Disability (as defined in the Services Agreement), and (iv) Dr. Kenyon's employment being terminated either by the Company without Cause or by Dr. Kenyon for Good Reason (as defined in the Services Agreement). In the event of a Change of Control (as defined in the Services Agreement), 50% of any unvested portion of the Kenyon Options and the Kenyon RSUs shall vest immediately prior to such event. | ||||||||||||||||||||
Dr Kenyon [Member] | AUD Currency [Member] | Services Agreement [Member] | ||||||||||||||||||||||
Annual salary | $ 54,000 |